JJ Holst, C Ørskov - Diabetes, 2004 - Am Diabetes Assoc Glucagon-like peptide (GLP)-1 is a gut hormone that stimulates insulin
secretion, gene expression, and ß-cell growth. Together with the related
hormone glucose-dependent insulinotropic polypeptide (GIP), it is ... Cited by 45 - Related articles - BL Direct - All 4 versions
R Mentlein - eid, 2005 - informahealthcare.com The most prevalent form of diabetes is non-insulin-dependent or Type 2 dia-
betes. Innovative strategies to enhance insulin secretion and thereby improve
glucose tolerance in patients with this type of diabetes are currently ... Cited by 13 - Related articles - BL Direct - All 6 versions
MA Nauck - Hormone and Metabolic Research, 2004 - thieme-connect.com Glucagon-like peptide 1 (GLP-1) was discovered as an incretin (insulinotropic
gut) hormone. Biological actions of GLP-1 in healthy and type 2 diabetic
subjects include (a) stimulation of insulin secretion in a ... Cited by 38 - Related articles - All 5 versions
T Vilsbøll, JJ Holst - Diabetologia, 2004 - Springer When glucose is taken orally, insulin secretion is stim- ulated much more than
it is when glucose is infused intravenously so as to result in similar glucose
con- centrations. This effect, which is called the incretin ef- fect and is ... Cited by 145 - Related articles - BL Direct - All 7 versions
JJ Holst - emd, 2004 - informahealthcare.com 1. What is glucagon-like peptide-1? 2. Effects of glucagon-like peptide-1 3.
Glucagon-like peptide-1-based therapy of Type 2 diabetes mellitus 4. Expert
opinion and conclusion ... For reprint orders, please contact: ... Cited by 50 - Related articles - All 6 versions
- ►aspetjournals.org N Irwin, BD Green, MH Mooney, B Greer, P … - Journal of Pharmacology and Experimental …, 2005 - ASPET Glucose-dependent insulinotropic polypeptide (GIP) is a gastrointestinal hormone
with a potentially therapeutic role in type 2 diabetes. Rapid degradation by
dipeptidylpeptidase IV has prompted the development of enzyme-resistant N- ... Cited by 22 - Related articles - BL Direct - All 7 versions
JJ Holst, C Orskov - Scandinavian Journal of Clinical and Laboratory …, 2001 - Informa Pharma Science Incretin hormones are insulinotropic hormones from the intestinal mucosa, which
after being released in response to ingestion of a meal, enhance insulin
secretion in excess of that elicited by the absorbed nutrients (glucose, ... Cited by 51 - Related articles - BL Direct - All 6 versions
JJHC Ørskov - Scandinavian Journal of Clinical & Laboratory …, 2001 - informahealthcare.com Incretin hormones are insulinotropic hormones from the intestinal mucosa, which
after being released in response to ingestion of a meal, enhance insulin
secretion in excess of that elicited by the absorbed nutrients (glucose, ... Related articles
HU Demuth, CHS McIntosh, RA Pederson - BBA-Proteins and Proteomics, 2005 - Elsevier This was demonstrated in rat applying the specific DP IV inhibitor isoleucyl
thiazolidine. It was published in 1996 for the first time that a specific DP IV
inhibitor in a given dose was able to completely block glucagon-like ... Cited by 79 - Related articles - All 3 versions
- ►physiology.org JJ Holst, J Gromada - American Journal of Physiology- Endocrinology And …, 2004 - Am Physiological Soc The available evidence suggests that about two-thirds of the insulin response to
an oral glucose load is due to the potentiating effect of gut-derived incretin
hormones. The strongest candidates for the incretin effect are ... Cited by 180 - Related articles - BL Direct - All 4 versions
